Multicentric Randomised Trial for Resectable Gastric Cancer

NCT02931890 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

207

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin
DRUG: Capecitabine
PROCEDURE: gastrectomy
RADIATION: radiotherapy of gastric cancer
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

The Netherlands Cancer Institute